JP2022502467A5 - - Google Patents
Info
- Publication number
- JP2022502467A5 JP2022502467A5 JP2021519843A JP2021519843A JP2022502467A5 JP 2022502467 A5 JP2022502467 A5 JP 2022502467A5 JP 2021519843 A JP2021519843 A JP 2021519843A JP 2021519843 A JP2021519843 A JP 2021519843A JP 2022502467 A5 JP2022502467 A5 JP 2022502467A5
- Authority
- JP
- Japan
- Prior art keywords
- insulin
- intermediate compound
- analog
- desb30
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2018/109562 | 2018-10-10 | ||
| CN2018109562 | 2018-10-10 | ||
| EP18204512 | 2018-11-06 | ||
| EP18204512.0 | 2018-11-06 | ||
| PCT/EP2019/077276 WO2020074544A1 (en) | 2018-10-10 | 2019-10-09 | Oligomer extended insulin-fc conjugates and their medical use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022502467A JP2022502467A (ja) | 2022-01-11 |
| JP2022502467A5 true JP2022502467A5 (enExample) | 2022-10-18 |
Family
ID=68138115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519843A Withdrawn JP2022502467A (ja) | 2018-10-10 | 2019-10-09 | オリゴマー伸長インスリン−ｆｃコンジュゲートおよびそれらの医学的使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210393745A1 (enExample) |
| EP (1) | EP3863680A1 (enExample) |
| JP (1) | JP2022502467A (enExample) |
| CN (1) | CN112839681A (enExample) |
| WO (1) | WO2020074544A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3355931B1 (en) | 2015-10-01 | 2024-06-26 | Novo Nordisk A/S | Protein conjugates |
| WO2022132709A1 (en) * | 2020-12-14 | 2022-06-23 | Eli Lilly And Company | Methods of treating diabetes |
| AR127619A1 (es) | 2021-11-15 | 2024-02-14 | Lilly Co Eli | FORMULACIONES CONSERVADAS DE FUSIONES DE INSULINA-Fc |
| EP4700044A1 (en) | 2023-03-31 | 2026-02-25 | Shanghai Duomirui Biotechnology., Ltd. | Protein analogue and use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| ATE279947T1 (de) | 1996-03-18 | 2004-11-15 | Univ Texas | Immunglobulinähnliche domäne mit erhöhten halbwertszeiten |
| HUE029512T2 (en) | 2006-09-22 | 2017-03-28 | Novo Nordisk As | Protease Resistant Insulin Analogs |
| AR081066A1 (es) | 2010-04-02 | 2012-06-06 | Hanmi Holdings Co Ltd | Conjugado de insulina donde se usa un fragmento de inmunoglobulina |
| JP2018508504A (ja) * | 2015-02-17 | 2018-03-29 | ハンミ ファーマシューティカル カンパニー リミテッド | 持続型インスリンまたはインスリンアナログ結合体 |
| AR105616A1 (es) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| CN107743494B (zh) | 2015-06-02 | 2022-04-29 | 诺和诺德股份有限公司 | 具有极性重组延伸体的胰岛素 |
| MA49339A (fr) * | 2017-04-05 | 2020-02-12 | Novo Nordisk As | Conjugués insuline-fc à extension oligomère |
-
2019
- 2019-10-09 JP JP2021519843A patent/JP2022502467A/ja not_active Withdrawn
- 2019-10-09 US US17/284,332 patent/US20210393745A1/en not_active Abandoned
- 2019-10-09 CN CN201980067002.3A patent/CN112839681A/zh not_active Withdrawn
- 2019-10-09 WO PCT/EP2019/077276 patent/WO2020074544A1/en not_active Ceased
- 2019-10-09 EP EP19783042.5A patent/EP3863680A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7658877B2 (ja) | インクレチン類似体およびその使用 | |
| US9944687B2 (en) | Compounds and their effects on feeding behaviour | |
| JP2016523243A5 (enExample) | ||
| JP2013517307A5 (enExample) | ||
| JP6058646B2 (ja) | 多置換インスリン | |
| JP2018505859A5 (enExample) | ||
| JP7237590B2 (ja) | 肥満の治療のためのグルカゴン及びｇｌｐ－１コアゴニスト | |
| JP2024538705A5 (enExample) | ||
| JP2019531320A5 (enExample) | ||
| JP2017105819A5 (enExample) | ||
| RU2012128547A (ru) | Дважды ацилированные производные glp-1 | |
| JP2022509568A5 (enExample) | ||
| US9458219B2 (en) | Human insulin analogue and acylated derivative thereof | |
| JP2005528337A5 (enExample) | ||
| BR112022005461A2 (pt) | Composto de glp-1 | |
| JP2012505637A5 (enExample) | ||
| RU2006120079A (ru) | Производные глюкагоноподобного пептида-1 (glp-1) | |
| JP2017508741A5 (enExample) | ||
| JP2012504619A5 (enExample) | ||
| JP2013523618A5 (enExample) | ||
| JP2023530515A5 (enExample) | ||
| JP2016529253A5 (enExample) | ||
| JP2023506952A (ja) | インクレチン類似体およびその使用 | |
| KR20130018965A (ko) | 목적 펩타이드의 혈장내 반감기 연장 작용을 가진 펩타이드 | |
| RU2012150108A (ru) | Аналоги глюкагоноподобного пептида-1 и их применение |